The impact of PEAR 1 polymorphism on clinical outcomes in Chinese patients receiving dual antiplatelet therapy after percutaneous coronary intervention

被引：6
|
作者：
Hu, Xinyuan [1 ]
Liu, Chaoxi [2 ]
Zhang, Mingyou [2 ]
Zhang, Weihua [2 ]
机构：
[1] First Hosp Jilin Univ, Genet Diag Ctr, Changchun 130021, Peoples R China
[2] First Hosp Jilin Univ, Dept Cardiol, Changchun 130021, Peoples R China
来源：
PHARMACOGENOMICS | 2022年 / 23卷 / 11期
关键词：
aspirin; genetic polymorphisms; PCI; PEAR1; CLOPIDOGREL RESPONSIVENESS; PLATELET REACTIVITY; RECEPTOR;
D O I：
10.2217/pgs-2022-0033
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Background: Patients might still experience major adverse cardiovascular events even with dual antiplatelet therapy after percutaneous coronary intervention. Our study aimed to explore the impact of gene polymorphism on clinical outcomes in one-year follow-up. Methods: A total of 171 patients treated with dual antiplatelet therapy after percutaneous coronary intervention from April to December 2020 in the first hospital of Jilin University enrolled in this study. Results: PEAR1 genetic polymorphisms was associated with the arachidonic acid (AA) and adenosine diphosphate (ADP) platelet aggregation. Hyperglycemia was associated with the rate of major adverse cardiovascular events. PEAR1 GA+AA genetic genetic polymorphisms is associated with hyperglycemia. Conclusion: PEAR1 GG is a risk factor for AA and ADP platelet aggregation. Hyperglycemia can effect the one-year outcome. PEAR1 GA+AA genetic polymorphisms are associated with hyperglycemia.
引用
收藏
页码：639 / 648
页数：10
相关论文
共 50 条
  • [21] The Challenges of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in Cancer Patients
    Tomdio, Anna N.
    Bottinor, Wendy
    Jovin, Ion S.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2022, 42 : 108 - 109
  • [22] Antiplatelet Therapy After Percutaneous Coronary Intervention
    Natsuaki, Masahiro
    Kimura, Takeshi
    CIRCULATION JOURNAL, 2022, 86 (05) : 741 - 747
  • [23] Antiplatelet therapy after percutaneous coronary intervention
    Angiolillo, Dominick J.
    Galli, Mattia
    Collet, Jean-Philippe
    Kastrati, Adnan
    O'Donoghue, Michelle L.
    EUROINTERVENTION, 2022, 17 (17) : E1371 - E1396
  • [24] Outcomes of Percutaneous Coronary Intervention Performed With or Without Preprocedural Dual Antiplatelet Therapy
    Ikegami, Yukinori
    Kohsaka, Shun
    Miyata, Hiroaki
    Ueda, Ikuko
    Fuse, Jun
    Sakamoto, Munehisa
    Shiraishi, Yasuyuki
    Numasawa, Yohei
    Negishi, Koji
    Nakamura, Iwao
    Maekawa, Yuichiro
    Momiyama, Yukihiko
    Fukuda, Keiichi
    CIRCULATION JOURNAL, 2015, 79 (12) : 2598 - +
  • [25] Update on dual antiplatelet therapy for percutaneous coronary intervention
    Prasad, Abhiram
    Holmes, David R.
    HEART, 2009, 95 (11) : 861 - 865
  • [26] Incidence Predictors Of Discontinued Dual Antiplatelet Therapy Among Patients After Percutaneous Coronary Intervention
    Jiang, Jie
    Zheng, Bo
    Zhang, Yan
    Yu, Ronghui
    Huo, Yong
    Hong, Tao
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C135 - C135
  • [27] Incidence and Predictors Of Prolonged Dual Antiplatelet Therapy Among Patients After Percutaneous Coronary Intervention
    Zheng, Bo
    Jiang, Jie
    Zhang, Yan
    Yu, Ronghui
    Huo, Yong
    Hong, Tao
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C134 - C135
  • [28] One vs 12 Months of Dual Antiplatelet Therapy for Patients After Percutaneous Coronary Intervention
    Tan, Wei Keith
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (17): : 1715 - 1715
  • [29] Understanding Differences in Sex-Based Outcomes with Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
    Akin, Ibrahim
    Hamdani, Nazha
    El-Battrawy, Ibrahim
    DRUGS, 2024, : 703 - 705
  • [30] Dual Antiplatelet Therapy Discontinuation, Platelet Reactivity, and Adverse Outcomes After Successful Percutaneous Coronary Intervention
    Redfors, Bjorn
    Kirtane, Ajay J.
    Liu, Mengdan
    Musikantow, Daniel R.
    Witzenbichler, Bernhard
    Rinaldi, Michael J.
    Metzger, D. Christopher
    Weisz, Giora
    Stuckey, Thomas D.
    Brodie, Bruce R.
    Ben-Yehuda, Ori
    Mehran, Roxana
    Stone, Gregg W.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (08) : 797 - 806
12345